Παρακολούθηση
Khalid Al-Rasadi
Khalid Al-Rasadi
Sultan Qaboos University, Director of Medical Research Center, Associate Professor, Department of
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα squ.edu.om - Αρχική σελίδα
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.
MD Dial S, Alrasadi K, Manoukian C, Huang A
Canadian Medical Association Journal, 2004
767*2004
Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel
Expert Opin Drug Saf. 14 (6), 935-955, 2015
593*2015
Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.
Arch Med Sci. 11 (1), 1-23, 2015
593*2015
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe …
RD Santos, SS Gidding, RA Hegele, MA Cuchel, PJ Barter, GF Watts, ...
The lancet Diabetes & endocrinology 4 (10), 850-861, 2016
4052016
Potential effects of curcumin in the treatment of COVID‐19 infection
F Zahedipour, SA Hosseini, T Sathyapalan, M Majeed, T Jamialahmadi, ...
Phytotherapy Research 34 (11), 2911-2920, 2020
3562020
Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways
K Koushki, SK Shahbaz, K Mashayekhi, M Sadeghi, ZD Zayeri, MY Taba, ...
Clinical reviews in allergy & immunology 60, 175-199, 2021
2982021
Statins and the COVID-19 main protease: in silico evidence on direct interaction
Ž Reiner, M Hatamipour, M Banach, M Pirro, K Al-Rasadi, T Jamialahmadi, ...
Archives of Medical Science 16 (3), 490-496, 2020
2972020
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ...
The Lancet 398 (10312), 1713-1725, 2021
2442021
Overview of the current status of familial hypercholesterolaemia care in over 60 countries-The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
AJ Vallejo-Vaz, M De Marco, CAT Stevens, A Akram, T Freiberger, ...
Atherosclerosis 277, 234-255, 2018
2172018
Familial hypercholesterolaemia: a global call to arms
AJ Vallejo-Vaz, SRK Seshasai, D Cole, GK Hovingh, JJP Kastelein, ...
Atherosclerosis 243 (1), 257-259, 2015
2042015
Reducing the clinical and public health burden of familial hypercholesterolemia: a global call to action
KA Wilemon, J Patel, C Aguilar-Salinas, CD Ahmed, M Alkhnifsawi, ...
JAMA cardiology 5 (2), 217-229, 2020
1982020
2023 update on European atherosclerosis society consensus statement on homozygous familial hypercholesterolaemia: new treatments and clinical guidance
M Cuchel, FJ Raal, RA Hegele, K Al-Rasadi, M Arca, M Averna, ...
European heart journal 44 (25), 2277-2291, 2023
1672023
Natural approaches in metabolic syndrome management
AM Patti, K Al-Rasadi, RV Giglio, D Nikolic, C Mannina, G Castellino, ...
Archives of Medical Science 14 (2), 422-441, 2018
1362018
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: a consensus statement from the …
JC Fruchart, RD Santos, C Aguilar-Salinas, M Aikawa, K Al Rasadi, ...
Cardiovascular diabetology 18, 1-20, 2019
1332019
International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia
GF Watts, SS Gidding, RA Hegele, FJ Raal, AC Sturm, LK Jones, ...
Nature Reviews Cardiology 20 (12), 845-869, 2023
1312023
Estimated glomerular filtration rate (eGFR): a serum creatinine-based test for the detection of chronic kidney disease and its impact on clinical practice
ARD Mula-Abed WA, Al Rasadi K
Oman medical journal 27 (4), 339, 2012
131*2012
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: rationale and design of the global EAS …
AJ Vallejo-Vaz, A Akram, SRK Seshasai, D Cole, GF Watts, GK Hovingh, ...
Atherosclerosis Supplements 22, 1-32, 2016
1272016
Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS)
N Danchin, W Almahmeed, K Al-Rasadi, J Azuri, A Berrah, CA Cuneo, ...
European journal of preventive cardiology 25 (10), 1087-1094, 2018
1252018
Vascular calcifications in homozygote familial hypercholesterolemia
Z Awan, K Alrasadi, GA Francis, RA Hegele, R McPherson, J Frohlich, ...
Arteriosclerosis, thrombosis, and vascular biology 28 (4), 777-785, 2008
1222008
Nutraceuticals in the management of dyslipidemia: which, when, and for whom? Could nutraceuticals help low-risk individuals with non-optimal lipid levels?
AFG Cicero, F Fogacci, AP Stoian, M Vrablik, K Al Rasadi, M Banach, ...
Current atherosclerosis reports 23, 1-14, 2021
1012021
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20